嗜异性抗体干扰影响多项罗氏免疫检测:一例病例研究
本文报告一例14岁男性因游离甲状腺素(fT4)极度升高被疑诊甲亢,但临床表现不符。复查结果不一致,比较罗氏与西门子Centaur平台发现罗氏检测fT4极度升高而西门子结果正常。经配对标本多平台检测、倍比稀释及嗜异性抗体评估,确定嗜异性抗体干扰为最可能原因。
要点
- 免疫检测结果与临床表现不符时需警惕嗜异性抗体干扰。
- 不同平台检测结果不一致可提示干扰存在。
- 倍比稀释和嗜异性抗体评估有助于确认干扰。
核心结论
- 嗜异性抗体干扰是导致该患者多项罗氏免疫检测结果异常的最可能原因。
研究设计与样本
- 病例报告:一名14岁男性,因疑似甲亢转诊儿科内分泌科。
主要发现
- 罗氏平台检测fT4极度升高,而西门子Centaur平台检测结果在正常范围内。
- 配对标本多平台检测、倍比稀释及嗜异性抗体评估支持嗜异性抗体干扰。
临床怎么用
- 当免疫检测结果与临床不符或不同平台结果不一致时,应考虑嗜异性抗体干扰并咨询实验室。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Analysis of many clinically important analytes is dependent on antibody-based assays. However, depending on the design, these assays are vulnerable to interference from endogenous molecules including circulating antibodies and free biotin. In this case report, we describe a patient whose laboratory findings from immunoassay based methodologies, are inconsistent with the clinical presentation. CASE PRESENTATION: A 14-year-old male was referred to Pediatric Endocrinology for suspected hyperthyroidism based on critically elevated free thyroxine (fT4) levels although clinical assessment was inconsistent with hyperthyroidism. Because repeat testing was discrepant, Endocrinology questioned the validity of the results prompting consultation with the laboratory to investigate the source of the inconsistent findings. Review of discordant results revealed that fT4 levels measured in laboratories utilizing Roche instrumentation were critically high, while results from laboratories using alternative platforms (i.e. Siemens Centaur) were within normal limits. CONCLUSION: After a comprehensive evaluation which included testing of paired specimens on multiple platforms, measurement of serially diluted specimens and a formal evaluation for the presence of heterophile antibodies, it was determined that a heterophile antibody interference was the most likely cause of the aberrant results in this patient.
引用
- Serei VD, Marshall I, Carayannopoulos MO, et al. Heterophile antibody interference affecting multiple Roche immunoassays: A case study. Clin Chim Acta. 2019. PMID: 31325446. doi:10.1016/j.cca.2019.07.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。